350574 <common-name>[(e)-[3-[8-(2-nitrobenzoyl)-3,8-diazabicyclo[3.2.1]octan-3-yl]-3-phenylpropylidene]amino] n-(4-methoxyphenyl)carbamate</common-name> <description>[(e)-[3-[8-(2-nitrobenzoyl)-3,8-diazabicyclo[3.2.1]octan-3-yl]-3-phenylpropylidene]amino] n-(4-methoxyphenyl)carbamate is a chemical compound with the formula C30H31N5O6. With an average molecular weight of 557.60 g/mol, [(e)-[3-[8-(2-nitrobenzoyl)-3,8-diazabicyclo[3.2.1]octan-3-yl]-3-phenylpropylidene]amino] n-(4-methoxyphenyl)carbamate is a heavy molecule.</description> <cas nil="true"/> <pubchem-id>24837382</pubchem-id> <chemical-formula>C30H31N5O6</chemical-formula> <weight>557.6</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:43:33Z</created-at> <updated-at type="dateTime">2026-08-31T15:43:33Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>COC1=CC=C(C=C1)NC(=O)ON=CCC(C2=CC=CC=C2)N3CC4CCC(C3)N4C(=O)C5=CC=CC=C5[N+](=O)[O-]</moldb-smiles> <moldb-formula>C30H31N5O6</moldb-formula> <moldb-inchi>InChI=1S/C30H31N5O6/c1-40-25-15-11-22(12-16-25)32-30(37)41-31-18-17-27(21-7-3-2-4-8-21)33-19-23-13-14-24(20-33)34(23)29(36)26-9-5-6-10-28(26)35(38)39/h2-12,15-16,18,23-24,27H,13-14,17,19-20H2,1H3,(H,32,37)/b31-18+</moldb-inchi> <moldb-inchikey>LCBMUBCAVXSAHB-FDAWAROLSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">557.2274337</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.3</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346467</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>[(e)-[3-[8-(2-nitrobenzoyl)-3,8-diazabicyclo[3.2.1]octan-3-yl]-3-phenylpropylidene]amino] n-(4-methoxyphenyl)carbamate</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Benzenoids</superklass> <klass>Benzene and substituted derivatives</klass> <subklass>Nitrobenzenes</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300879</sync-id> <structure-inchikey>LCBMUBCAVXSAHB-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000000000000000000800000000000000800000800000100000000000000000000000000000000200020002000010004000000000000000000000000000080000000000010002000000000000000000020000000000300001a04001000400000050000010000010250004000000000000000020500000000000000000000100000000040001401800000800000000084000000001100200000000000004000000000080004000000000400080000000000000001000000000000008000000080000000000400000000000000000000200000000000000000000202000000000000008008000200000040000000020400000000001000200108000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAApAAAALQAAAIABBgBgAAAAAQMIACgAAAAD AgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEG QGgAAAADAwEHAGgAAAADAgEGACgAAAADBAgAKAAAAAMCCAAoAAAAAwIHACgA AAADAwYAaAAAAAMDAQYAYAAAAAICBgBgAAAAAwEGQCgAAAADBAZAaAAAAAMD AQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQcAIAAAAAMG AGAAAAACAgYAYAAAAAMBBgBgAAAAAgIGAGAAAAACAgYAYAAAAAMBBgBgAAAA AgIHACgAAAADAwYAKAAAAAMECAAoAAAAAwIGQCgAAAADBAZAaAAAAAMDAQZA aAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEByAqAAAAAQMECAAo AAAAAwIIICoAAAD/AwELAAEAAQIgAgNoDAMEaAwEBWgMBQZoDAYHaAwFCCAI CSAJCigCCQsgCwwgDA0oAg0OAA4PAA8QABARaAwREmgMEhNoDBMUaAwUFWgM DxYAFhcAFxgAGBkAGRoAGhsAGxwAGx0AHR4gHh8oAh4gICAhaAwhImgMIiNo DCMkaAwkJWgMJSYgJicoAiYoIAcCaAwVEGgMHBYAHRgAJSBoDEIFAAAABgIH BgUEAwYREhMUFRAGFxgdGxwWBRkYHRsaBiEiIyQlIBcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:34Z</structure-indexed-at> </compound>